Citalopram and desmethylcitalopram in vitro: human cytochromes mediating transformation, and cytochrome inhibitory effects
- 1 September 1999
- journal article
- Published by Elsevier in Biological Psychiatry
- Vol. 46 (6) , 839-849
- https://doi.org/10.1016/s0006-3223(98)00353-9
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Kinetic Characterization and Identification of the Enzymes Responsible for the Hepatic Biotransformation of Adinazolam and N-Desmethyladinazolam in ManJournal of Pharmacy and Pharmacology, 1998
- Five Distinct Human Cytochromes Mediate Amitriptyline N‐Demethylation In Vitro: Dominance of CYP 2C19 and 3A4The Journal of Clinical Pharmacology, 1998
- Protease Inhibitors as Inhibitors of Human Cytochromes P450: High Risk Associated with RitonavirThe Journal of Clinical Pharmacology, 1998
- Selective Serotonin Reuptake Inhibitors and CNS Drug InteractionsClinical Pharmacokinetics, 1997
- CitalopramCNS Drugs, 1997
- Use of In Vitro and In Vivo Data to Estimate the Likelihood of Metabolic Pharmacokinetic InteractionsClinical Pharmacokinetics, 1997
- Clinically Relevant Pharmacology of Selective Serotonin Reuptake InhibitorsClinical Pharmacokinetics, 1997
- Metabolism of Drugs by Cytochrome P450 3A IsoformsClinical Pharmacokinetics, 1995
- The pharmacological effect of citalopram resides in the (S)-(+)-enantiomerJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1992
- CitalopramDrugs, 1991